Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Narayana Hrudayalaya Ltd (NH) is currently trading at 1,739.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business. Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible. The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization. Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,380.05 and a high of ₹2,371.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Narayana Hrudayalaya Ltd has a market capitalization of approximately 35,563.89. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Narayana Hrudayalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 45.38 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 35,563.89 Cr, Narayana Hrudayalaya Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Narayana Hrudayalaya Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 45.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The most significant positive is the proposed scheme to develop five regional medical hubs in partnership with the private sector, which will provide a major boost to the medical tourism segment, a key strength for Narayana Hrudayalaya.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1740.25 | 35,564 Cr | 45.38 | 8.76 | 0.26 | 20.82 | 17.75 | 10.07 | |
649.55 | 33,655 Cr | 102.40 | 8.04 | 0.74 | 8.18 | 10.11 | 4.60 | |
1105.05 | 29,840 Cr | 57.84 | 8.05 | 0.00 | 15.15 | 16.83 | 9.50 | |
706.35 | 28,264 Cr | 94.18 | 12.45 | 0.00 | 14.80 | 10.88 | 4.75 | |
432.25 | 13,749 Cr | 108.98 | 7.12 | 0.00 | 5.94 | 9.26 | 4.25 | |
1210.00 | 12,288 Cr | 47.70 | 8.09 | 0.25 | 16.72 | 17.60 | 10.05 | |
1297.00 | 8,470 Cr | 45.08 | 5.84 | 0.08 | 13.66 | 15.60 | 9.33 |
Scheme Meeting Notice
Narayana Hrudayalaya Ltd published newspaper ads (The Hindu & Udayavani) on Feb 27, 2026 notifying members and creditors of meetings on Apr 02, 2026 (via VC/OAVM) as directed by NCLT Bengaluru for approval of the scheme with NH Integrated Care Pvt Ltd.
Scheme of Arrangement
Narayana Hrudayalaya published newspaper ads (The Hindu, Udayavani) on Feb 27, 2026 notifying members/creditors of VC meetings on Apr 2, 2026 convened as directed by NCLT Bengaluru to consider a scheme of arrangement between NH Integrated Care Pvt Ltd and Narayana Hrudayalaya Ltd.
Scheme Meeting Notice
Narayana Hrudayalaya Ltd and NH Integrated Care Pvt Ltd will hold shareholder and creditors meetings (including unsecured creditors) on April 2, 2026 via VC/OAVM as directed by NCLT Bengaluru to approve a Scheme of Arrangement; remote e‑voting Mar 30–Apr 1.
Scheme Meeting Notice
Pursuant to NCLT Bengaluru order dated Feb 13, 2026, Narayana Hrudayalaya Ltd and NH Integrated Care Pvt Ltd will hold shareholder and creditor meetings on Apr 2, 2026 to approve the Scheme of Arrangement; remote e‑voting Mar 30–Apr 1, 2026.
Scheme of Arrangement
Narayana Hrudayalaya Ltd. will convene shareholders and creditors meetings (via VC/OAVM) on April 2, 2026, as directed by NCLT Bengaluru, to seek approval for the scheme of arrangement with NH Integrated Care Pvt. Ltd.; e‑voting Mar 30–Apr 1, 2026.
Scheme of Arrangement
Narayana Hrudayalaya Ltd., as directed by NCLT Bengaluru (Order dated Feb 13, 2026), has convened shareholders and creditors meetings on April 2, 2026 to approve the Scheme of Arrangement with NH Integrated Care Pvt. Ltd.; remote e‑voting Mar 30–Apr 1, 2026.
Bearish
2
Neutral
3
Bullish
9
Bearish
34
Neutral
3
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business.
Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible.
The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization.
Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.
Healthcare
Hospitals / Medical Services
35,564 Cr
Low Risk
45.4
60.2
2.0
8.8
2,371.60
1,380.05
Sales CAGR
Profit CAGR
ROE
ROCE
